GUANGJI PHARMA
0009525.490.92% ( +0.05 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: GUANGJI PHARMA(000952) the Revenue is 163.09 M (+9.84%);the EBIT is -21.7 M (+30%);the EPS is -0.0913 (+11.96%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.16B9.84%
----
----
EBIT
-0.02B30.00%
----
----
EPS
-0.091311.96%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf